Moderna (MRNA) Current Assets (2017 - 2026)
Moderna (MRNA) posted quarterly Current Assets of $5.8 billion for Q2 2026, down 5.77% year-over-year from $6.2 billion in Q2 2025, and up 0.78% on a QoQ basis from $5.8 billion in Q1 2026.
Moderna (MRNA) Current Assets (2017 - 2026) Analysis & Trends
Moderna has reported Current Assets for 10 years, with the latest figure at $5.8 billion in Q2 2026.
- Current Assets for Q2 2026 came in at $5.8 billion, down 5.77% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.8 billion (down 5.77% YoY), and the FY2025 annual result was $6.5 billion, down 19.2% from the prior year.
- Current Assets rose to $5.8 billion in Q2 2026, from $5.8 billion in the prior quarter.
- Over five years, Current Assets peaked at $16.4 billion in Q1 2022 and troughed at $5.8 billion in Q1 2026.
- A 5-year average of $9.8 billion and a median of $9.7 billion in 2024 frame the typical range for Current Assets.
- The widest annual swing landed in 2022, when Current Assets surged 39.71%; it then tumbled 36.12% in 2025.
- A 5-year view of Current Assets shows it stood at $13.4 billion in 2022, then retreated by 23.13% to $10.3 billion in 2023, then decreased by 21.56% to $8.1 billion in 2024, then declined by 19.2% to $6.5 billion in 2025, then dropped by 11.14% to $5.8 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $5.8 billion in Q2 2026, $5.8 billion in Q1 2026, and $6.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | 5.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.82 Bn |
| Mar 31, 2026 | 5.77 Bn |
| Dec 31, 2025 | 6.54 Bn |
| Sep 30, 2025 | 6.60 Bn |
| Jun 30, 2025 | 6.17 Bn |
| Mar 31, 2025 | 6.77 Bn |
| Dec 31, 2024 | 8.10 Bn |
| Sep 30, 2024 | 9.67 Bn |
| Jun 30, 2024 | 9.66 Bn |
| Mar 31, 2024 | 9.60 Bn |
| Dec 31, 2023 | 10.33 Bn |
| Sep 30, 2023 | 10.80 Bn |
| Jun 30, 2023 | 10.60 Bn |
| Mar 31, 2023 | 12.12 Bn |
| Dec 31, 2022 | 13.43 Bn |
| Sep 30, 2022 | 14.30 Bn |
| Jun 30, 2022 | 13.56 Bn |
| Mar 31, 2022 | 16.35 Bn |
| Dec 31, 2021 | 16.07 Bn |
| Sep 30, 2021 | 13.43 Bn |